United States · FDA National Drug Code directory
Eletriptan Hydrobromide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 59651-105_f505017a-a5d7-4f9a-a62f-06a28b30f645
- Product NDC
- 59651-105
- Form
- TABLET, FILM COATED
- Composition / generic term
- Eletriptan Hydrobromide
- Labeler
- Aurobindo Pharma Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20180216
- Source listing expiry
- 20261231
Source-listed ingredients
- ELETRIPTAN HYDROBROMIDE — 40 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BLISTER PACK in 1 CARTON (59651-105-69) / 6 TABLET, FILM COATED in 1 BLISTER PACK (59651-105-06) · 59651-105-69
- 2 BLISTER PACK in 1 CARTON (59651-105-93) / 6 TABLET, FILM COATED in 1 BLISTER PACK · 59651-105-93
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →